Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Cannabis Smoke Is Less Likely To Cause Cancer Than Tobacco Smoke

Science Daily & Medical News Today

Wednesday 19 Oct 2005

-----
Cannabis smoke is not as carcinogenic as tobacco smoke. In a review
article published today in Harm Reduction Journal, Dr. Melamede from the
University of Colorado, Colorado Springs, USA, writes that although
cannabis smoke and tobacco smoke are chemically very similar, evidence
suggests that their effects are very different and that cannabis smoke
is less carcinogenic than tobacco smoke.

The pharmacological effects of tobacco and cannabis smoke differ in many
ways, mainly because tobacco smoke contains nicotine while cannabis
smoke contains tetrahydrocannabinol (THC). The cancer-promoting effects
of smoke are increased by nicotine, while they are reduced by THC.

Tobacco and cannabis smoke contain the same carcinogenic compounds --
and depending on which part of the plant is smoked, cannabis smoke can
contain more of them -- but, whereas nicotine activates these
carcinogenic compounds, THC has been shown to inhibit them in mice
cells. THC is very likely to have protective effects against the
carcinogens present in smoke in humans too, but cannabis smoke remains
nonetheless carcinogenic.

While nicotine and THC can act on related cellular pathways, they bind
to different receptors to activate these pathways. The cells of lungs
and the respiratory passages are lined with nicotine receptors, but do
not appear to carry THC receptors. This explains why cannabis smoking
has not been associated with lung cancer, a main cause of death from
cigarette smoking.

Cannabis has also been shown to kill cancer cells and to reduce tumour
growth, in part by reducing the formation of blood vessels that feed
tumours. But "the effects of cannabinoids are complex and sometimes
contradicting", warns the author. In addition, as cannabis is frequently
smoked with tobacco, the effects of the two drugs may interact in
complex ways.

Cannabis is a class C drug in the UK and the USA. It has been linked to
an increased risk of psychosis and schizophrenia, in a small group of
vulnerable individuals. But there is increasing evidence that the drug
has significant medicinal uses and can greatly improve the lives of
patients suffering from a wide range of conditions, including multiple
sclerosis, AIDS, Alzheimer's disease and insomnia. In spite of this,
governments have been reluctant to legalize cannabis for medical use, on
the grounds that the risks associated with the drug still outweigh its
benefits.

http://www.sciencedaily.com/releases/2005/10/051019003339.htm
http://www.medicalnewstoday.com/medicalnews.php?newsid=32229

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!